Reviva Pharmaceuticals Holdings RVPH
OTC RVPH
$0.50 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Reviva Pharmaceuticals Holdings (RVPH) Interest & Investment Income (2018 - 2026)

Updated

Reviva Pharmaceuticals Holdings (RVPH) posted Interest & Investment Income of $176,319 for Q2 2026, up 671.7% from $22,847 a year earlier and up 97.3% from the prior quarter.

Analysis

Reviva Pharmaceuticals Holdings (RVPH) Interest & Investment Income (2018 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at Reviva Pharmaceuticals Holdings was $468,085, up 123.3% year-over-year; for FY2025, it came in at $311,370, down 13.8% from FY2024.

  • Annual Interest & Investment Income shows a five-year compound annual growth rate of 24.2% (FY2020 to FY2025).
  • In prior years, Reviva Pharmaceuticals Holdings' Interest & Investment Income was $361,369 in FY2024 (-9.3%), $398,413 in FY2023 (+117.9%), $182,802 in FY2022 and -$2,414 in FY2021.
  • The Q2 2026 figure stands as the highest quarterly Interest & Investment Income since Q3 2019.
  • On a year-over-year basis, Interest & Investment Income has increased in each of the last four quarters, with growth averaging 88.3% over the last eight quarters.
  • The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q2 2026, with growth of 671.7%; the weakest was Q2 2025, with a decline of 73.9%.
  • According to Business Quant data, Interest & Investment Income for the three prior quarters was $89,354 (Q1 2026), $143,309 (Q4 2025) and $59,103 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Reviva Pharmaceuticals Holdings 6.56 Mn 6.56 Mn - 176,319.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 176,319.00
Mar 31, 2026 89,354.00
Dec 31, 2025 143,309.00
Sep 30, 2025 59,103.00
Jun 30, 2025 22,847.00
Mar 31, 2025 86,111.00
Dec 31, 2024 47,413.00
Sep 30, 2024 53,248.00
Jun 30, 2024 87,610.00
Mar 31, 2024 173,098.00
Dec 31, 2023 56,559.00
Sep 30, 2023 91,763.00
Jun 30, 2023 103,080.00
Mar 31, 2023 147,011.00
Dec 31, 2022 114,092.00
Sep 30, 2022 53,150.00
Jun 30, 2022 13,825.00
Mar 31, 2022 1,735.00
Dec 31, 2021 1,534.00
Sep 30, 2021 -547.00
API Access

Reviva Pharmaceuticals Holdings Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=RVPH&period=max&api_key=YOUR_API_KEY